Cover Story
By Matthew Bin Han Ong
The vast majority of patients with prostate cancer in the United States don't receive androgen deprivation therapy injections on time. Up to 84% of injections are delayed for patients on a 28-day schedule, according to an authoritative study published in the The Journal of Urology.
In Brief
Clinical Roundup
Drugs & Targets
Trending Stories
- Trump 2016: A look back at the 45th president’s impact on oncology
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Trump to dedicate $500M over 10 years to childhood cancer
- The Cancer Letter’s most-read stories of 2024
- The unKOOL, unfiltered history of menthol cigarettes
- What will Trump’s return to the White House mean for oncology?
“Our work just got a lot more difficult.”